Financial News

Range Cancer Therapeutics Index (NQ: CNCR )

14.74 +0.16 (+1.10%)

Official Closing Price Updated: 4:15 PM EDT, Nov 1, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Range Cancer Therapeutics Index

3 Top-Ranked ETFs Under $20 For Your Portfolio

June 07, 2024

Let us dig into some of the ETFs that are below $20 and have a strong buy rating. These low-priced ETFs could lead to huge gains in the coming months based on market trends.

Via Talk Markets

Topics ETFs

5 Market-Beating Sector ETFs Of Q1

March 27, 2024

Here are some of the top performers in the ETF space from different sectors of the market.

Via Talk Markets

Topics ETFs

5 Sector ETFs Beating The Market Halfway Through Q1

February 12, 2024

After a weak start to 2024, Wall Street regained momentum, with all three major indices logging their fifth straight week of gains.

Via Talk Markets

Topics ETFs

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector

March 15, 2023

To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.

Via InvestorPlace

5 Top-Ranked ETFs To Buy At Bargain Prices For 2023

January 04, 2023

Here are five ETFs from different zones that have plunged the most over the past year but are poised to outperform when the market resumes its uptrend.

Via Talk Markets

5 ETFs Riding High On The Biotech Comeback

July 09, 2022

The high-growth biotech segment has borne the maximum brunt of the broader market sell-off.

Via Talk Markets

3 Promising Oncology Stocks To Consider Adding To Your Portfolio

June 14, 2021

With tech integration and DNA sequencing increasing the efficacy of potential cancer drugs in the pipeline, we believe biotech names AstraZeneca, Amgen and Incyte are worth adding to a portfolio.

Via Talk Markets

Best Biotech Stocks & ETFs for mRNA, Gene Editing

April 29, 2021

2020 was the most challenging year in decades but it was great for scientific innovation, particularly in the biotech space.

Via Talk Markets

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

Range Cancer Therapeutics Index (NQ: CNCR )

Headline News about Range Cancer Therapeutics Index

Popular Pages